85 MEMORIAL ROAD, #415, WEST HARTFORD, CT
Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Veradermics, Inc. Closes $384.4M Public Offering of Common Stock
Preliminary Cash Position of $390.8 Million as of March 31, 2026
Investor Presentation
Financial Results, Press Release
Fifth Restated Certificate of Incorporation Filed for IPO
Q1
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
S-1
Registration Statement for Securities to be Offered to Employees
Certificate
Registration of Securities
No filings found
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Schedule 13D - Ownership Report
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Free Writing Prospectus
S-1MEF